RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kingworld Medicines Group Stock

Kingworld Medicines Group Net Income 2024

Kingworld Medicines Group Net Income

38.1 M CNY

Ticker

1110.HK

ISIN

KYG5268M1006

In 2024, Kingworld Medicines Group's profit amounted to 38.1 M CNY, a 67.52% increase from the 22.74 M CNY profit recorded in the previous year.

The Kingworld Medicines Group Net Income history

YEARNET INCOME (undefined CNY)
202338.1
202222.74
202130.32
202011.72
201943.43
201841.01
201751.06
201646.97
201531.21
201437.87
201347.2
201248.5
201151
201042.9
200937.2
200834.4
200729.2

Kingworld Medicines Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kingworld Medicines Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kingworld Medicines Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kingworld Medicines Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kingworld Medicines Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kingworld Medicines Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kingworld Medicines Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kingworld Medicines Group’s growth potential.

Kingworld Medicines Group Revenue, EBIT and net profit per share

DateKingworld Medicines Group RevenueKingworld Medicines Group EBITKingworld Medicines Group Net Income
20231.08 B undefined78.68 M undefined38.1 M undefined
2022957.7 M undefined80.34 M undefined22.74 M undefined
2021847.39 M undefined71.24 M undefined30.32 M undefined
2020745.38 M undefined65.5 M undefined11.72 M undefined
2019977.93 M undefined69.03 M undefined43.43 M undefined
20181.08 B undefined63.3 M undefined41.01 M undefined
20171.03 B undefined62.67 M undefined51.06 M undefined
20161.05 B undefined99.17 M undefined46.97 M undefined
2015713.55 M undefined53.18 M undefined31.21 M undefined
2014660.32 M undefined49.53 M undefined37.87 M undefined
2013554.8 M undefined28.9 M undefined47.2 M undefined
2012626.8 M undefined48.1 M undefined48.5 M undefined
2011685.6 M undefined56 M undefined51 M undefined
2010638 M undefined48.9 M undefined42.9 M undefined
2009556.4 M undefined44.2 M undefined37.2 M undefined
2008536 M undefined47.9 M undefined34.4 M undefined
2007527.3 M undefined33.4 M undefined29.2 M undefined

Kingworld Medicines Group stock margins

The Kingworld Medicines Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kingworld Medicines Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kingworld Medicines Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kingworld Medicines Group's sales revenue. A higher gross margin percentage indicates that the Kingworld Medicines Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kingworld Medicines Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kingworld Medicines Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kingworld Medicines Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kingworld Medicines Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kingworld Medicines Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kingworld Medicines Group Margin History

Kingworld Medicines Group Gross marginKingworld Medicines Group Profit marginKingworld Medicines Group EBIT marginKingworld Medicines Group Profit margin
202326.02 %7.29 %3.53 %
202228.99 %8.39 %2.37 %
202131.11 %8.41 %3.58 %
202037.59 %8.79 %1.57 %
201927.34 %7.06 %4.44 %
201828.87 %5.87 %3.8 %
201731.33 %6.08 %4.95 %
201630.71 %9.41 %4.46 %
201531.78 %7.45 %4.37 %
201423.67 %7.5 %5.73 %
201323.65 %5.21 %8.51 %
201223.47 %7.67 %7.74 %
201123.45 %8.17 %7.44 %
201021.96 %7.66 %6.72 %
200921.69 %7.94 %6.69 %
200824.14 %8.94 %6.42 %
200718.26 %6.33 %5.54 %

Kingworld Medicines Group Aktienanalyse

What does Kingworld Medicines Group do?

Kingworld Medicines Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Kingworld Medicines Group's Profit Margins

The profit margins of Kingworld Medicines Group represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Kingworld Medicines Group's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Kingworld Medicines Group's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Kingworld Medicines Group's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Kingworld Medicines Group’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Kingworld Medicines Group stock

How much profit has Kingworld Medicines Group made this year?

Kingworld Medicines Group has made 38.1 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by 67.52% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Kingworld Medicines Group publish its earnings?

Kingworld Medicines Group publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Kingworld Medicines Group?

The profits of Kingworld Medicines Group are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Kingworld Medicines Group?

You can learn more about the earnings of Kingworld Medicines Group by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Kingworld Medicines Group pay?

Over the past 12 months, Kingworld Medicines Group paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 6.56 %. For the coming 12 months, Kingworld Medicines Group is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Kingworld Medicines Group?

The current dividend yield of Kingworld Medicines Group is 6.56 %.

When does Kingworld Medicines Group pay dividends?

Kingworld Medicines Group pays a quarterly dividend. This is distributed in the months of July, June, July, July.

How secure is the dividend of Kingworld Medicines Group?

Kingworld Medicines Group paid dividends every year for the past 13 years.

What is the dividend of Kingworld Medicines Group?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 6.56 %.

In which sector is Kingworld Medicines Group located?

Kingworld Medicines Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kingworld Medicines Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kingworld Medicines Group from 6/30/2024 amounting to 0.034 CNY, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Kingworld Medicines Group pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Kingworld Medicines Group in the year 2023?

In the year 2023, Kingworld Medicines Group distributed 0.024 CNY as dividends.

In which currency does Kingworld Medicines Group pay out the dividend?

The dividends of Kingworld Medicines Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kingworld Medicines Group

Our stock analysis for Kingworld Medicines Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kingworld Medicines Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.